← SynDRA
PADSEVONIL
SynDRA canonical compound SYN0039667 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | antiepileptic |
All known targets
Mechanisms of action (all sources)
- SV2A MODULATOR
- Synaptic vesicle protein modulator
- SV2B MODULATOR
- SV2C MODULATOR
- antiepileptic
- SV2A INHIBITOR
Drug classes
Cross-references
Synonyms
- UCB0942
- UCB-0942
- UCB-1415943-000
- UCB1415943-000
- Anticonvulsant (epilepsy), UCB
- UNII-0R1HN52K0N
- (R)-4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl)methyl)pyrrolidin-2-one
- (4R)-4-(2-Chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)pyrrolidin-2-one
- (4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one
- Padsevonil [INN]
- Padsevonil [USAN]
- Padsevonil (JAN/USAN)
- SCHEMBL1672843
- CHEMBL4297521
- WHO 10384
- DB14977
- SB18725
- HY-109009
- CS-0030507
- D11842
- Q27237119
- (4R)-4-(2-Chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)(1,3,4)thiadiazol-5-yl)methyl)-2-pyrrolidinone
- 2-Pyrrolidinone, 4-(2-chloro-2,2-difluoroethyl)-1-((2-(methoxymethyl)-6-(trifluoromethyl)imidazo(2,1-b)-1,3,4-thiadiazol-5-yl)methyl)-, (4R)-
- 0R1HN52K0N
- padsevonilum
- RefChem:928486
- C14H14ClF5N4O2S
- PADSEVONIL [JAN]
- Padsevonil [USAN:INN]
- PADSEVONIL [WHO-DD]
- orb1706850
- DCXFIOLWWRXEQH-SSDOTTSWSA-N
- GLXC-21559
- EX-A5541
- MFCD31692352
- AKOS040742361
- DA-56551
- MS-27726
- G16368
Look up PADSEVONIL in the interactive SynDRA portal →